Mehul Patel

Dynamic and results-driven pharmaceutical executive with over 18 years of global leadership experience in R&D, Project Management, Commercial strategy and business development. Proven success in launching new products, scaling operations, and leading cross-functional teams to exceed revenue goals. Deep understanding of regulatory environments and go-to-market models across key global markets.

Creative analytical thinkers work closely with higher management to prepare and execute the strategies. Small molecule CDMO management from both Techno-commercial competency across the Solid and Injectable dosage forms. Founding member of the company to Key player in the successful IPO launch for Senores Group.

Aggressive working style with solution-oriented leadership. Consider work and fun as a core part of healthy culture. Believe in everything possible approach.

Follow

Motto of Company First, Team second and Personal as the least priority.

General Manager at Senores Pharmaceutical Limited (2018-02 – Present)

Managing team size of 12 people across the North America and India sites. Strategic Leadership, Business Development & Alliance Management, CMO-CDMO Business Management, M&A & Licensing, Launch and Commercialization, Client-Centric Growth, Revenue and Profitability, Market Intelligence, Integrated Collaboration, Go-to-Market Planning, and Commercial Operations.

• Managing team size of 12 people across the North America and India sites
• Define and communicate commercial vision, ensuring alignment with group's overall strategic plan
• Serve as a thought leader in healthcare communications and commercialization
• Spearhead initiatives to win new clients and expand existing relationships
• Turned CMO-CDMO Business vertical into key revenue generating unit for overall P&L within 3 years
• Playing key role for asset & IP M&A deals with track record of more than 50 deals (Deal Value >$1bn)
• Lead efforts to develop and launch strategy with Marketing partners and in-house sales team
• Act as a trusted advisor to clients, understanding their challenges and opportunities
• Develop and implement pricing models, revenue forecasts, and profitability metrics
• Overall revenue & Profit growth reported is an average of 30-40% YOY
• Conduct deep dives into therapeutic areas, emerging markets, and new technologies
• Work closely with cross-functional teams for seamless execution of commercial initiatives
• Oversee the creation and execution of comprehensive go-to-market strategies

Senior Manager at Amneal Pharmaceuticals (2014-12 – 2018-02)

Leading portfolio of more than $5 BN revenue generating products from complex Injectable, Ophthalmic and Oncology Injectable dosage forms. Finalizing agreement and handling all the external CMO-CDMO projects. Responsible for entire project life cycle management from early-stage development to commercialization.

• Leading portfolio of more than $5 BN revenue generating products
• Complex Injectable, Ophthalmic and Oncology Injectable dosage forms management
• Finalizing agreement and handling all the external CMO-CDMO projects
• Responsible for entire project life cycle management from early-stage development to commercialization
• Support in reviewing products under P-IV challenge to identify potential candidates for authorized generics

Research Scientist at Wockhardt Limited (2013-09 – 2014-12)

Formulation Development & Process development as per USFDA guidelines. Successfully developed processes for complex dosage form and technology transfer at manufacturing site.

• Formulation Development & Process development as per USFDA guidelines
• Successfully developed processes for complex dosage form and technology transfer at manufacturing site
• Strategy preparations for the execution of BE studies and trials
• Executed multiple trouble shooting projects at the production floor
• Help achieving commercial viable products

Senior Executive at Cadila Healthcare Limited (2009-09 – 2013-08)

Formulation Development, Technology transfer and successful launch execution for Complex Oral solid and oncology molecule. Successfully developed and launched high revenue earning molecules.

• Formulation Development, Technology transfer and successful launch execution for Complex Oral solid and oncology molecule
• Successfully developed and launched high revenue earning molecules
• First ever Oncology new lab setup, file products and commercially launch molecules in Cadila group history
• Successful Development, Filling, and approval for solid oncology formulations
• Four times awarded as a 'STAR PERFORMER' for the effective contribution
• Two times faced successful patent litigation against brand companies

Research Associate at Cadila Pharmaceuticals (2008-06 – 2009-09)

Formulation Development, Technology transfer and successful launch execution for Complex Oral solid products. Process Development, Technology transfer and troubleshooting.

• Formulation Development, Technology transfer and successful launch execution for Complex Oral solid products
• Process Development, Technology transfer and troubleshooting are major focused area

Master of Business Administration in Business Administration – IIM-Kozhikode (2022-01 – 2024-01)

Master of Pharmacy in Pharmacy – Vinayaka Mission University (2006-01 – 2008-01)

Bachelor of Pharmacy in Pharmacy – Gujarat University (2002-01 – 2006-01)